adenocarcinoma

(redirected from adenocarcinoma of the prostate)
Also found in: Dictionary, Thesaurus, Medical, Acronyms.
Related to adenocarcinoma of the prostate: Gleason scale
?Note: This page may contain content that is offensive or inappropriate for some readers.

adenocarcinoma:

see neoplasmneoplasm
or tumor,
tissue composed of cells that grow in an abnormal way. Normal tissue is growth-limited, i.e., cell reproduction is equal to cell death. Feedback controls limit cell division after a certain number of cells have developed, allowing for tissue repair
..... Click the link for more information.
.

adenocarcinoma

[¦ad·ən‚ō‚kär·sən′ō·mə]
(medicine)
A malignant tumor originating in glandular or ductal epithelium and tending to produce acinic structures.
References in periodicals archive ?
The etiology of mucinous adenocarcinoma of the prostate remains unclear, and it is thought that the risk factors for mucinous adenocarcinoma of the prostate are similar to those for adenocarcinoma of the prostate, which are related to genetic, environmental, androgen, and other factors.
Ductal adenocarcinoma of the prostate: immunohistochemical findings and clinical significance.
Transdural metastasis from adenocarcinoma of the prostate mimicking subdural hematoma.
Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II.
Adenocarcinoma of the prostate: a comparison of the disease in blacks versus whites.
Gleason score 7 adenocarcinoma of the prostate with lymph node metastases: analysis of 184 radical prostatectomy specimens.
Adenocarcinoma of the prostate is the second most common cancer in men, with the majority of cases detected after the age of 60.
Histopathological examination of the radical orchiectomy specimens demonstrated metastatic adenocarcinoma of the prostate showing reactivity with PSA and keratin without any positive reactivity with calretinin, CD117, CD30, vimentin, inhibin, octamer-binding transcription factor 3/4 or placental-like alkaline phosphatase (Figure 3).
This immunohistochemical panel was not suggestive of primary adenocarcinoma of the prostate but could correspond either to a primary vesical or a colonic adenocarcinoma.
Aberrant diffuse expression of p63 in adenocarcinoma of the prostate on needle biopsy and radical prostatectomy: report of 21 cases.
It was first reported in 1979 and is estimated to occur in 2.5% of cases of adenocarcinoma of the prostate. (1) Although SRCC is primarily found in the stomach and colon, it can also be found in the pancreas, breast, thyroid, bladder, and prostate.